Terumo Corporation
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, int… Read more
Terumo Corporation (TRUMF) - Total Assets
Latest total assets as of December 2025: $2.26 Trillion USD
Based on the latest financial reports, Terumo Corporation (TRUMF) holds total assets worth $2.26 Trillion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Terumo Corporation - Total Assets Trend (2001–2025)
This chart illustrates how Terumo Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Terumo Corporation - Asset Composition Analysis
Current Asset Composition (March 2025)
Terumo Corporation's total assets of $2.26 Trillion consist of 39.6% current assets and 60.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.1% |
| Accounts Receivable | $176.85 Billion | 9.7% |
| Inventory | $294.38 Billion | 16.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $251.36 Billion | 13.8% |
| Goodwill | $293.22 Billion | 16.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Terumo Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Terumo Corporation's current assets represent 39.6% of total assets in 2025, a decrease from 48.0% in 2001.
- Cash Position: Cash and equivalents constituted 12.1% of total assets in 2025, down from 14.3% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 1.0% in 2001.
- Asset Diversification: The largest asset category is inventory at 16.1% of total assets.
Terumo Corporation Competitors by Total Assets
Key competitors of Terumo Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Terumo Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Terumo Corporation generates 0.57x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Terumo Corporation generates $6.40 in net profit.
Terumo Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.51 | 2.79 | 2.48 |
| Quick Ratio | 0.89 | 1.62 | 1.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $276.09 Billion | $ 472.12 Billion | $ 312.60 Billion |
Terumo Corporation - Advanced Valuation Insights
This section examines the relationship between Terumo Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.85 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -0.2% |
| Total Assets | $1.83 Trillion |
| Market Capitalization | $18.47 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Terumo Corporation's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Terumo Corporation's assets decreased by 0.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Terumo Corporation (2001–2025)
The table below shows the annual total assets of Terumo Corporation from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $1.83 Trillion | -0.16% |
| 2024-03-31 | $1.83 Trillion | +14.30% |
| 2023-03-31 | $1.60 Trillion | +8.72% |
| 2022-03-31 | $1.47 Trillion | +9.07% |
| 2021-03-31 | $1.35 Trillion | +8.85% |
| 2020-03-31 | $1.24 Trillion | +10.76% |
| 2019-03-31 | $1.12 Trillion | +3.87% |
| 2018-03-31 | $1.08 Trillion | +5.64% |
| 2017-03-31 | $1.02 Trillion | +13.28% |
| 2016-03-31 | $901.68 Billion | -9.11% |
| 2015-03-31 | $992.07 Billion | +19.12% |
| 2014-03-31 | $832.81 Billion | +8.01% |
| 2013-03-31 | $771.03 Billion | +11.34% |
| 2012-03-31 | $692.52 Billion | +64.87% |
| 2011-03-31 | $420.04 Billion | -1.29% |
| 2010-03-31 | $425.51 Billion | +12.25% |
| 2009-03-31 | $379.06 Billion | -7.75% |
| 2008-03-31 | $410.92 Billion | +11.94% |
| 2007-03-31 | $367.08 Billion | +3.52% |
| 2006-03-31 | $354.60 Billion | +13.49% |
| 2005-03-31 | $312.45 Billion | +6.34% |
| 2004-03-31 | $293.84 Billion | +1.98% |
| 2003-03-31 | $288.12 Billion | +1.21% |
| 2002-03-31 | $284.67 Billion | +1.09% |
| 2001-03-31 | $281.60 Billion | -- |